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The ponA gene encoding penicillin-binding protein 1 (PBP 1) from Neisseria gonorrhoeae was cloned by a
reverse genetic approach. PBP 1 was purified from solubilized membranes of penicillin-susceptible strain FA19
by covalent ampicillin affinity chromatography and used to obtain an NH2-terminal amino acid sequence. A
degenerate oligonucleotide based on this protein sequence and a highly degenerate oligonucleotide based on a
conserved amino acid motif found in all class A high-molecular-mass PBPs were used to isolate the PBP 1 gene
(ponA). The ponA gene encodes a protein containing all of the conserved sequence motifs found in class A PBPs,
and expression of the gene in Escherichia coli resulted in the appearance of a new PBP that comigrated with
PBP 1 purified from N. gonorrhoeae. A comparison of the gonococcal ponA gene to its homolog isolated from
Neisseria meningitidis revealed a high degree of identity between the two gene products, with the greatest
variability found at the carboxy terminus of the two deduced PBP 1 protein sequences.
Penicillin and other b-lactam antibiotics, by virtue of their
structural similarity to the D-Ala-D-Ala carboxy terminus of
nascent peptidoglycan, exert their lethal action by covalently
binding to and inactivating enzymes involved in bacterial cell
wall biosynthesis (26). Inhibition of these enzymes, known as
penicillin-binding proteins or PBPs, prevents the normal cross-
linking of the peptide chains of peptidoglycan and results in
cell death. The pathogenic gram-negative organism Neisseria
gonorrhoeae has three PBPs, denoted PBPs 1, 2, and 3 (1).
PBPs 1 and 2 are the major antibiotic killing targets for N.
gonorrhoeae, whereas PBP 3 is not essential for cell viability
(1). Because PBP 2 has an approximately 10-fold higher affinity
for penicillin G than PBP 1, penicillin kills N. gonorrhoeae at its
MIC by inactivation of PBP 2 (1).
Early isolates of pathogenic N. gonorrhoeae were extremely
sensitive to penicillin. However, penicillin-resistant strains
have now emerged which have greatly reduced the efficacy of
this antibiotic in the treatment of gonococcal infections. Pen-
icillin resistance in N. gonorrhoeae has arisen by two major
mechanisms: the plasmid-mediated production of a TEM-1
b-lactamase and by chromosomally mediated expression of
multiple-resistance genes (3). In chromosomally mediated re-
sistance, alterations of both membrane permeability and es-
sential PBPs have resulted in a 1,000-fold increase in the MIC
for penicillin. However, the genetic and biochemical events
underlying penicillin resistance in these strains have yet to be
fully elucidated (7, 10). Since high-level penicillin resistance
(MIC $ 2 mg/ml) is always correlated with expression of an
altered PBP 1 with a decreased affinity for penicillin (6, 7), it is
highly likely that the PBP 1 gene is involved in mediating
high-level penicillin resistance.
In order to delineate the role of PBP 1 in chromosomally
mediated, high-level penicillin resistance, we have cloned the
gene encoding PBP 1 (ponA) from N. gonorrhoeae FA19, a
penicillin-susceptible laboratory strain. The ponA sequence
shows significant homology to PBPs from other bacteria and
contains all of the conserved sequence motifs found in high-
molecular-mass PBPs. In addition, we report the sequence of
the ponA gene from Neisseria meningitidis.
Purification and NH2-terminal sequencing of PBP 1. Due to
the lack of a genetic selection for PBP 1, a reverse genetic
approach was used to clone the PBP 1 gene. Large quantities
of strain FA19 were grown in liquid culture, and membranes
were prepared from these cells. PBP 1 was extracted from the
membrane preparation and purified by covalent ampicillin af-
finity chromatography (25). Figure 1 shows an aliquot of pu-
rified PBP 1 separated by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE). A major staining band
at a molecular mass of ;90 kDa was visible among multiple
lightly stained bands throughout the lane (Fig. 1A, lane 3).
When purified PBP 1 was incubated with 125I-penicillin V prior
to electrophoresis and autoradiographed, it was covalently la-
beled with the radioactive antibiotic and comigrated with 125I-
penicillin V-labeled PBP 1 from FA19 membranes (Fig. 1B,
lanes 1 and 2). In addition to PBP 1, several other bands of
lower intensity were observed (Fig. 1B). The two minor bands
directly below PBP 1 represent proteins that comigrated with
PBPs 2 and 3, which likely copurified with PBP 1. These PBPs
are only minor contaminants in the PBP 1 preparation since
PBP 2 is not released efficiently from the antibiotic resin with
hydroxylamine and PBP 3 is not readily extracted from the
membranes by 1% Triton X-100–1 M NaCl (23a). The band
above PBP 1 represents a PBP 1 dimer, since this band was
recognized by polyclonal antibodies raised against PBP 1 (data
not shown).
Aliquots of PBP 1 were separated by SDS-PAGE, electro-
blotted onto polyvinylidene difluoride membranes, and sub-
jected to NH2-terminal amino acid sequencing. A 25-amino-
acid sequence, IKKILTT(?)FGLFFGF(?)VFGVGLVAI (the
question marks stand for unknown amino acids), was obtained
from the blotted protein. This amino acid sequence showed no
significant homology to any other high-molecular-mass PBPs
cloned to date or to any other known bacterial proteins.
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Cloning of the ponA gene encoding PBP 1. Two degenerate
oligonucleotides were used to clone the PBP 1 gene. The first
oligonucleotide (GC2) was based on a region of the PBP 1
NH2-terminal peptide sequence, FGLFFGF, whereas the sec-
ond oligonucleotide (GC5) corresponded to a highly conserved
amino acid sequence (the QGAST box [22]) found in all class
A high-molecular-mass PBPs cloned to date. Duplicate filter
lifts of an FA19 DraI lZapII phage library (4) were probed
separately with GC2 and GC5, and three clones that hybrid-
ized to both probes were isolated and plaque purified.
Sequence analysis of the 2.6-kb DraI fragment in the three
clones revealed a long open reading frame (ORF) spanning
2,397 bp and encoding a protein 798 amino acids in length (Fig.
2). Although two in-frame methionine codons 21 bp apart were
identified at the start of the ORF, the sequence predicted from
the second translation start site was identical to the NH2-
terminal sequence derived from the purified protein. Thus, the
second methionine codon appears to be the preferred start
site. Neither ATG codon is preceded by an optimal ribosomal
binding site sequence. The stop codon of the ORF is contained
within the DraI restriction site (TTT T2AA AGA; the DraI
site is underlined, the cleavage site is indicated by the vertical
arrows, and the stop codon is in boldface). The protein product
deduced from this ORF had a calculated molecular mass of
88,425 Da, very close to the size of PBP 1 derived from SDS-
PAGE. The transcriptional start site was determined by primer
extension to be 65 bp upstream of the ATG start codon (Fig.
2; also data not shown). While there are no strong matches to
235 and 210 consensus promoter sequences upstream of the
transcriptional start site, the best matches to the 235 (TTGA
CA) and 210 (TATAAT) consensus sequences are TGAAAG
and TACAGT, respectively, which are spaced 15 bp apart (Fig.
2). Three copies of the 10-bp gonococcal uptake sequence
GCCGTCTGAA (9) were identified within the sequenced re-
gion of the ponA gene. A single copy, found within the ORF of
the ponA gene, was identified on the noncoding strand at
nucleotides 1672 to 1681 (Fig. 2). Two additional copies are
present within the inverted repeats immediately downstream
of the ponA stop codon. The occurrence of uptake sequences
within the inverted repeats has been observed previously in the
gonococcal uvrB gene (2). We have named this gene ponA in
accordance with the nomenclature used for Escherichia coli
(24).
Analysis of the deduced amino acid sequence of ponA re-
vealed all of the features characteristic of class A high-molec-
ular-mass PBPs. PBP 1 contains a 25-amino-acid region of high
hydrophobicity very near the NH2 terminus that likely func-
tions as both a noncleavable signal sequence and a transmem-
brane anchor. Following this region is the putative transglyco-
sylase domain that catalyzes polymerization of the glycan
chains of peptidoglycan. The regions comprising residues 88 to
97, 117 to 127, and 286 to 293 correspond to boxes 1, 2, and 4,
respectively, described by Ghuysen and Dive (13) and display
a significant conservation of amino acids when compared to
other class A PBPs. These conserved regions may play a role in
forming the active site of the putative transglycosylase domain
of these multifunctional proteins. Within the carboxy-terminal
transpeptidase domain of PBP 1 three regions can be found
that are highly conserved in all members of the penicilloyl
serine transferase superfamily. These regions include the
SXXK tetrad containing the active-site serine at residues 461
to 464, the SXN triad at residues 521 to 523, and the KT(S)G
tetrad at residues 651 to 654 (Fig. 2). On the basis of the
three-dimensional structures of several b-lactamases (5, 15,
19), the Streptomyces R61DD-peptidase (16), and PBP 2x from
Streptococcus pneumoniae (20), it has been determined that
these conserved motifs are brought close together in the folded
protein to form the active-site pocket that interacts with b-lac-
tam antibiotics.
Comparison of the predicted amino acid sequence of PBP 1
with other class A high-molecular-mass PBPs with the GAP
alignment program of the Genetics Computer Group indicated
that N. gonorrhoeae PBP 1 displays the highest sequence iden-
tity to E. coli PBP 1A (41.7%), followed by Haemophilus in-
fluenzae PBP 1 (38.6%), S. pneumoniae PBP 1 (31%), Strepto-
coccus oralis PBP 1 (31%), Bacillus subtilis PBP 1 (31%), and
E. coli PBP 1B (31%).
Comparison of the ponA sequences from FA19, FA1090, and
N. meningitidis Z2491. With primers derived from the FA19
ponA gene sequence, the ponA genes from FA1090 and N.
meningitidis Z2491 (group A serotype) were amplified by PCR
and subcloned into pUC19K. Individual clones were then se-
quenced. The ponA gene sequence from FA1090 was 100%
identical to that from FA19. The ponA gene from N. meningi-
tidis contained 62 nucleotide changes compared to the FA19
sequence, which corresponds to an overall nucleotide identity
of 97.6%. However, these changes were not distributed equally
throughout the gene. Instead, the differences in the nucleotide
sequence of the meningococcal gene were clustered at the very
39 end of the coding sequence (Fig. 2). There were 29 nucle-
otide changes within the last 124 bp of the gene (76.6% iden-
tity), compared to 33 nucleotide changes throughout the first
2,270 bp of the gene (98.5% identity). Consequently, a similar
pattern was seen at the amino acid level; the proteins were
98.8% identical within the first 758 amino acid residues (749/
758) versus 70% identical (28/40) within the carboxy-terminal
40 amino acids.
Expression of PBP 1 in E. coli. To confirm that the ponA
gene encodes PBP 1, both the gonococcal and the meningo-
coccal genes were subcloned into the expression vector
pET15b (Novagen, Madison, Wis.) and transformed into E.
coli BL21(DE3) cells. Membranes were prepared from over-
FIG. 1. Analysis of purified PBP 1 from FA19 gonococcal membranes and
overexpression in E. coli. PBP 1 was purified from supernatants of Triton X-100-
solubilized FA19 membranes as described previously (25) and subjected to SDS-
PAGE. (A) Coomassie brilliant blue staining. Lane 1, 1.5 mg each of protein
standards; lane 2, 20 mg of FA19 membranes; lane 3, 2 mg of purified PBP 1. (B)
Autoradiography of an identical gel in which the protein samples were incubated
with 125I-penicillin V prior to SDS-PAGE. Lane 1, FA19 membranes; lane 2,
purified PBP 1. (C) Expression in E. coli. The ponA gene was cloned into the
expression plasmid pET15b and expressed in E. coli BL21(DE3). Membranes
were prepared from cells, and aliquots were incubated with 125I-penicillin V
prior to SDS-PAGE and autoradiography. Lane 1, membranes prepared from
bacteria transformed with the expression construct containing the gonococcal
ponA gene; lane 2, membranes prepared from bacteria transformed with the
expression construct containing the meningococcal ponA gene; lane 3, mem-
branes prepared from bacteria transformed with the pET15b vector alone. Mo-
lecular mass standards are in kilodaltons.
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FIG. 2. Nucleotide sequences of the ponA genes encoding PBP 1 from both N. gonorrhoeae and N. meningitidis and deduced amino acid sequences. Duplicate filters
of a lZapII library (kindly provided by Fred Sparling) containing EcoRI-linkered fragments from DraI-digested FA19 DNA were hybridized separately with 32P-labeled
oligonucleotides GC2 (59-ATIGCIACIARICCIAC-39 where R 5 A or G and I 5 inosine) or GC5 (59-SARGGIGSIWSIRCIHTIACICARCARYT-39 where H 5 A,
C, or T; S 5 C or G; W 5 A or T; and Y 5 C or T). Three clones hybridizing to both probes were plaque purified, and plasmid DNA was excised by using the
ExAssist/Solr system protocol (Stratagene, La Jolla, Calif.). The clones were then sequenced using Sequenase version 2.0 (Amersham, Arlington, Heights, Ill.). The
gonococcal PBP 1 amino acid sequence from FA19 is shown above the nucleotide sequence. The nucleotide sequence of the meningococcal PBP 1 gene is on the lines
indicated by asterisks, and identical nucleotides are denoted by a dot. Differences in the amino acid sequences of the species homologs are shown on the lines marked
'. Inverted repeat sequences capable of functioning as transcription terminators are indicated by the horizontally opposed arrows at the 39 end of the gene. The putative
transmembrane domain is denoted by the unshaded box at the NH2 terminus of the translated protein, whereas the shaded boxed regions highlight the amino acid
sequences conserved in the active-site regions of all penicillin-binding proteins. The active-site serine is indicated by the solid bullet. The conserved class A
high-molecular-mass PBP consensus sequence used in the cloning of the PBP 1 gene is indicated by the shaded, unboxed region. The transcriptional start site of the
ponA gene is indicated by the arrow, and putative promoter elements are overlined. Three 10-bp gonococcal DNA uptake sequences are underlined.
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night cultures, incubated with 125I-penicillin V, and subjected
to SDS-PAGE. Autoradiography of the gel revealed the ex-
pression of a new PBP in cells containing the ponA gene from
both neisserial species; the new PBP comigrated with PBP 1
purified from N. gonorrhoeae FA19 (Fig. 1C). These data in-
dicate that the cloned ponA genes from both N. gonorrhoeae
and N. meningitidis encode PBP 1.
Measurement of the affinities of 125I-penicillin V for native
and E. coli-expressed PBP 1. The affinities of PBP 1 isolated
from FA19 membranes and of both gonococcal and meningo-
coccal PBP 1 overexpressed in bacteria for 125I-penicillin V
were measured by a modified version of the protocol described
by Barbour (1). The affinity of a PBP is defined as the concen-
tration of antibiotic that results in the covalent labeling of 50%
of that PBP under defined conditions of time of incubation and
temperature (14). Aliquots of Triton X-100-solubilized mem-
branes were incubated with serial dilutions of 125I-penicillin V
for 20 min at 378C and were subjected to SDS-PAGE. Radio-
labeled PBP 1 proteins were then quantitated with a Storm 840
PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.).
The data in Fig. 3 show that the overexpressed gonococcal PBP
1 and meningococcal PBP 1 (affinities, 0.3 and 0.2 mg/ml,
respectively) have affinities 3.5- to 5-fold higher than that of
native PBP 1 from FA19 membranes (affinity, 1.1 mg/ml). The
reason for the small differences between the affinities of PBP 1
from FA19 and PBP 1 overexpressed in E. coli for 125I-peni-
cillin V is not known but may involve differences in the amount
of PBP 1 protein assayed or the presence of another protein in
gonococcal membranes that alters the affinity of PBP 1 for the
antibiotic. Barbour (1) reported an affinity of PBP 1 in FA19
membranes for [3H]penicillin G of 0.2 nmol/ml (;0.095 mg/
ml), which is approximately 2-fold higher than the affinity of
the E. coli-expressed gonococcal PBP 1 for 125I-penicillin V
and 10-fold higher than the affinity of FA19 PBP 1 for 125I-
penicillin V. These differences most likely are a result of the
structural differences between the two antibiotics.
Organization of the ponA gene region in N. gonorrhoeae and
deletion analysis of the ponA gene. Biochemical experiments
have indicated that PBP 1 is an essential protein in cell wall
synthesis. To confirm these experiments, we disrupted the
ponA gene by insertional inactivation and attempted to trans-
form the disrupted gene back into FA19. In order to obtain
sufficient upstream and downstream flanking sequences of the
ponA gene for the transformation experiments, we constructed
an EcoRI-restricted FA19 library in lDashII and screened the
library with a probe derived from the ponA gene. Several
positive clones that contained an approximately 12-kb EcoRI
insert were isolated, and sequence analysis of the DNA flank-
ing the ponA gene from one of these clones (l5-3; Fig. 4A)
revealed four ORFs upstream and oriented in the opposite
direction to the ponA gene and one ORF downstream of the
ponA gene, also oriented in the opposite direction. The four
ORFs upstream of the ponA gene were homologous to pilus
biosynthesis genes pilM, pilN, pilO, and pilP previously charac-
terized in Pseudomonas aeruginosa and Pseudomonas syringae
(17, 23). The FA19 pilO gene product is nearly identical to the
gonococcal strain MS11 pilO gene product, differing only by a
single amino acid residue. Similarly, the pilP gene, which spans
the EcoRI site of the clone and is therefore incomplete at its 39
FIG. 3. Affinities of native and recombinant PBP 1 for 125I-penicillin V.
Aliquots of Triton X-100-solubilized membranes were incubated with increasing
concentrations of 125I-penicillin V for 20 min at 378C. The samples were sub-
jected to SDS-PAGE on 10% gels, and the amount of radioactivity in the PBP 1
bands was quantitated with a Molecular Dynamics Storm 840 PhosphorImager.
■, FA19 membranes; F, gonococcal PBP 1 expressed in E. coli; å, meningococ-
cal PBP 1 expressed in E. coli.
FIG. 4. Genomic organization of the ponA gene and flanking regions. (A) Genomic organization of 6.4 kb of l DASHII clone 5-3 containing the ponA gene and
flanking ORFs. Arrows indicate the six ORFs identified by sequence analysis within this 6.4-kb fragment. The gene designation of each ORF is indicated. The direction
of transcription is indicated by the direction of the arrow. (B) Restriction map of the 6.4-kb fragment. Shown are the sites used to construct plasmids containing the
V fragment, as indicated below the restriction map. The sites are as follows: E, EcoRI; D, DraI; S, StyI; and P, PstI. Plasmids harboring the V fragment encoding
streptomycin/spectinomycin resistance within either the ponA coding region (pPR15) or the 39 noncoding region of the ponA gene (pPR16) were used in transformation
experiments as described in the text.
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end, is nearly identical (the gene products differ by two amino
acids) to the published pilP sequence of MS11 (8). The orga-
nization of the pilus biosynthesis genes relative to the ponA
gene in N. gonorrhoeae is identical to that of both P. aeruginosa
(17) and P. syringae (23). This organization was also consistent
with genomic mapping experiments (4a) that localized the
ponA gene ofN. gonorrhoeae near the omc gene recently shown
to encode PilQ (8). The ORF downstream of the ponA gene
(ORF1; Fig. 4A) encodes a polypeptide which shows signifi-
cant identity (46%) to a hypothetical GTP-binding protein of
unknown function in E. coli (21), H. influenzae (11), and My-
coplasma genitalium (12). Thus, ORF1 likely encodes the
gonococcal homolog of this hypothetical GTPase.
The plasmid pPR15 was constructed to replace an internal
525-bp StyI fragment of the ponA gene with the streptomycin/
spectinomycin resistance gene (the V fragment; Fig. 4B), re-
sulting in the insertional inactivation of the ponA gene. As a
control for transformation, the V fragment also was inserted
downstream of the ponA gene (pPR16; Fig. 4B). Transforma-
tion of competent FA19 with pPR15 resulted in no growth on
selective medium, even after 72 h. In contrast, transformation
of FA19 with pPR16 resulted in growth of streptomycin-resis-
tant colonies after 24 h of incubation. These results strongly
suggest that disruption of the ponA gene results in the loss of
viability of the gonococci and are consistent with previous
experiments indicating that PBP 1 is an essential protein in-
volved in cell wall synthesis in N. gonorrhoeae.
Chromosomally mediated penicillin resistance in N. gonor-
rhoeae has given rise to an altered PBP 1 with a reduced affinity
for penicillin G (6). The cloning of the ponA gene from N.
gonorrhoeae will allow us to address the role of PBP 1 in the
acquisition of high-level penicillin resistance in N. gonorrhoeae.
Cloning and sequencing of the ponA genes from several strains
resistant to high levels of penicillin may identify amino acid
mutations that result in a lower affinity of PBP 1 for penicillin
G. Similar studies have been carried out with the penA gene
encoding PBP 2 from multiple clinical isolates of penicillin-resis-
tant N. gonorrhoeae (18). These studies have shown that penicil-
lin-resistant isolates of N. gonorrhoeae andN. meningitidis contain
penA genes with mosaic structures that presumably have arisen
by horizontal transfer of penA genes from a commensal species
via transformation and homologous recombination. A similar
scenario may have occurred within the ponA genes of gono-
coccal isolates with high levels of penicillin resistance.
Finally, it is apparent that N. gonorrhoeae has a relatively
simple PBP pattern, with one low-molecular-mass PBP (PBP
3), one high-molecular-mass class B PBP (PBP 2), and one
high-molecular-mass class A PBP (PBP 1). This property makes
N. gonorrhoeae an excellent model system to study in order to
better understand the roles of these PBPs in cell morphogenesis,
since there appears to be no redundancy in its PBP complement.
Nucleotide sequence accession numbers. The nucleotide se-
quences reported in this paper have been submitted to the
GenBank database under the accession numbers U72876 and
U80933.
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